ClinicalTrials.Veeva

Menu

Safety and Performance of the Neuroform Atlas™ Stent System (ATLAS-FR)

Stryker logo

Stryker

Status

Unknown

Conditions

Intracranial Aneurysm

Treatments

Device: Neuroform Atlas Stent System

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

The objective of this retrospective study is to describe in real-life settings the clinical practice, utilization and the treated population outcomes at 1-year (12-16 months) follow-up at selected, representative centers in France.

Full description

This proposed ATLAS FR study will be a retrospective review conducted to expand our knowledge of the clinical outcomes in subjects treated in France between 01 February 2017 and 01 March 2018.

This will provide a comprehensive data set that is specifically representative of the Atlas stent use in France.

Enrollment

310 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patient who had undergone a stent assisted intracranial aneurysm coiling with Neuroform Atlas for the treatment of intracranial aneurysm(s) between 1st Feb 2017 and 1st March 2 018.
  • Patient and/or their representative have/has received the written information concerning the study and not expressed opposition to the collection of his data

Trial contacts and locations

1

Loading...

Central trial contact

Caroline Le Page, RN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems